He G. Endothelial NOS activity and myocardial oxygen metabolism define the salvageable ischemic time window for ischemic postconditioning. Am J Physiol Heart Circ Physiol 300: H1069 -H1077, 2011. First published January 7, 2011; doi:10.1152/ajpheart.00694.2010.-Ischemic postconditioning (IPOC) could be ineffective or even detrimental if the index ischemic duration is either too short or too long. The present study is to demonstrate that oxygen supply and metabolism defines a salvageable ischemic time window of IPOC in mice. C57BL/6 mice underwent coronary artery occlusion followed by reperfusion (I/R), with or without IPOC by three cycles of 10 s/10 s R/I. In vivo myocardial tissue oxygenation was monitored with electron paramagnetic resonance oximetry. Regional blood flow (RBF) was measured with a laser Doppler monitor. At the end of 60 min reperfusion, tissue from the risk area was collected, and mitochondrial enzyme activities were assayed. Tissue oximetry demonstrated that I/R induced a reperfusion hyperoxygenation state in the 30-and 45-min but not 15-and 60-min ischemia groups. IPOC attenuated the hyperoxygenation with 45 but not 30 min ischemia. RBF, eNOS phosphorylation, and mitochondrial enzyme activities were suppressed after I/R with different ischemic time, and IPOC afforded protection with 30 and 45 but not 60 min ischemia. Infarct size measurement indicated that IPOC reduced infarction with 30 and 45 min but not 60 min ischemia. Clearly, IPOC protected mouse heart with a defined ischemic time window between 30 and 45 min. This salvageable time window was accompanied by the improvement of RBF due to increased phosphorylated eNOS and the preservation of mitochondrial oxygen consumption due to conserved mitochondrial enzyme activities. Interestingly, this salvageable ischemic time window was mirrored by tissue hyperoxygenation status in the postischemic heart. ischemia and reperfusion; electron paramagnetic resonance; regional blood flow; tissue oxygenation; mitochondrial enzyme activity ISCHEMIC HEART DISEASE IS associated with high morbidity and mortality (2). Rapid initiation of reperfusion is the most effective treatment to reduce the infarction. However, the rapid influx of calcium ions and generation of reactive oxygen/ nitrogen species (ROS/RNS) inflict additional damage to the heart (6, 30). Ischemic preconditioning protects tissue and organs through increasing their tolerance to the prolonged ischemia. (12) However, clinical implementation of this strategy is limited due to the requirement of ischemic stimuli before the index ischemia. Postconditioning differs from its preconditioning counterpart in that the mechanical intervention is at the very beginning of reperfusion and therefore has the potential of clinical application. In 2003, Zhao et al. (45) reported that brief and repeated episodes of reperfusion and ischemia immediately after a sustained ischemic insult conferred cardioprotection against ischemia-reperfusion (I/R) injury in dogs, known as ischemic postconditioning (IPOC). Subsequent studies demonstrated that IPOC reduced myocardial infarction and decreased the incidence of arrhythmia in canine, rats, rabbits, and mice (13, 19, 27, 43) . Because ischemia is hard to predict in patients, IPOC is more practical for clinical implementation. In a landmark clinical study, postconditioning of human myocardium with brief repetitive balloon occlusions enhanced vasodilatory capacity of the distal vascular bed and improved reperfusion during percutaneous coronary intervention for acute myocardial infarction (21). IPOC after coronary angioplasty and stenting also protected human heart (35).
ISCHEMIC HEART DISEASE IS associated with high morbidity and mortality (2) . Rapid initiation of reperfusion is the most effective treatment to reduce the infarction. However, the rapid influx of calcium ions and generation of reactive oxygen/ nitrogen species (ROS/RNS) inflict additional damage to the heart (6, 30) . Ischemic preconditioning protects tissue and organs through increasing their tolerance to the prolonged ischemia. (12) However, clinical implementation of this strategy is limited due to the requirement of ischemic stimuli before the index ischemia. Postconditioning differs from its preconditioning counterpart in that the mechanical intervention is at the very beginning of reperfusion and therefore has the potential of clinical application. In 2003, Zhao et al. (45) reported that brief and repeated episodes of reperfusion and ischemia immediately after a sustained ischemic insult conferred cardioprotection against ischemia-reperfusion (I/R) injury in dogs, known as ischemic postconditioning (IPOC). Subsequent studies demonstrated that IPOC reduced myocardial infarction and decreased the incidence of arrhythmia in canine, rats, rabbits, and mice (13, 19, 27, 43) . Because ischemia is hard to predict in patients, IPOC is more practical for clinical implementation. In a landmark clinical study, postconditioning of human myocardium with brief repetitive balloon occlusions enhanced vasodilatory capacity of the distal vascular bed and improved reperfusion during percutaneous coronary intervention for acute myocardial infarction (21) . IPOC after coronary angioplasty and stenting also protected human heart (35) .
However, the effectiveness of postconditioning depends on the severity and duration of the index ischemia. With shortindex ischemia, postconditioning failed to reduce or even increased the infarct size in rats and pigs (25, 29, 31) . For example, the effect of IPOC on a rat model of 5 min ischemia followed by reperfusion was associated with improvement of ventricular arrhythmias but not myocardial infarction (20) . A 10 min myocardial ischemia is known to induce myocardial stunning without any infarction (33) , and IPOC did not limit stunning. Manintveld et al. (25) reported that, when rats were given three cycles of 30 s brief and repeated episodes of reperfusion and ischemia immediately after a 15-min index ischemia, the infarction was even worse. With the index ischemic time progressing, myocardial infarction increases and eventually IPOC can no longer afford any protection. For example, when ischemic time was extended to 120 min, there was no further protection of IPOC (25) .
To date, the molecular mechanisms for the protective effect of IPOC on myocardial infarct size sparing is still not completely understood (34) . Furthermore, the exact mechanisms for a potential salvageable ischemic time window of IPOC are still not clear, even though Manintveld et al. have clearly demonstrated the existence of a protectable ischemic window in rats (3, 25, 40) .
Our previous studies demonstrated that ROS/RNS suppressed mitochondrial respiration and induced myocardial tissue hyperoxygenation and I/R injury (41, 44) . We have also demonstrated that ischemic preconditioning protects the heart from I/R injury via attenuating the formation of ROS/RNS and the postischemic tissue hyperoxygenation (46) . However, there are no prior studies on the relationship of either the index ischemia duration or IPOC to the postischemic tissue hyperoxygenation. Because tissue oxygenation is a balance between oxygen supply and metabolism, we hypothesize that IPOC protects the heart against I/R injury via regulating mitochondrial oxygen consumption and eNOS-regulated oxygen supply through regional blood flow (RBF). To determine how I/R and IPOC regulate myocardial oxygen consumption, tissue PO 2 and RBF will be monitored. To determine how I/R and IPOC affect RBF, eNOS activity will be assayed. For in vivo tissue PO 2 measurement, electron paramagnetic resonance (EPR) oximetry will be employed with lithium phthalocyanine (LiPc) as the oxygen sensor (9, 17, 36, 44) .
With the assessment of eNOS phosphorylation and RBF, mitochondrial enzyme activities and myocardial tissue oxygenation, as well as myocardial infarction, the current study will determine the underlying mechanisms of IPOC on mouse hearts with different ischemic time duration to define a salvageable ischemic time window.
METHODS

Animals and chemicals.
Male C57BL/6 mice (8 wk, 22-25 g) were purchased from Jackson Laboratory (Bar Harbor, ME). All procedures were performed with the approval of the Institutional Animal Care and Use Committee at The Ohio State University, Columbus, OH, and conformed to the Guide for the Care and Use of Laboratory Animals (NIH publication no. 85-23, revised 1996). For NOS inhibition, N-nitro-L-arginine methyl ester (L-NAME; Sigma) was administered as needed to the mice in drinking water (1 mg/ml) for 3 days before surgery as described previously (44) .
Myocardial I/R model and IPOC protocol. The surgical procedures were similar to methods described previously (14, 16, 44) . For the I/R model, following left thoracotomy, the left anterior descending coronary artery (LAD) was completely ligated for 15, 30, 45, or 60 min. After different durations of ischemia, the ligature was removed for 60 min to obtain tissue oxygenation, RBF, and mitochondrial function and for 24 h for infarct size measurement. The sham group mice were subjected to the same surgery except LAD occlusion. Because isofluorane was used to maintain anesthesia in all animals and due to its cardioprotective effect (4), we included controls with the same isofluorance dosage for all experimental groups for comparison.
In the IPOC groups, after ischemia with different durations, mice were subjected to IPOC stimuli consisting of three cycles of 10 s perfusion/10 s reocclusion starting at the end of the index ischemia, followed by either 60 min (for EPR oximetry, RBF or mitochondrial enzyme activities) or 24 h (for infarct size) similar to that in the I/R mice.
EPR oximetry. After exposure of the heart, ϳ10 g of LiPc were implanted in the midmyocardium of the risk area. Next, EPR oximetry was performed after 30 min equilibration with the following parameters: frequency, 1.1 GHz; microwave power, 16 mW; modulation amplitude, 0.045 G. The EPR line width of LiPc responds linearly to tissue PO2 in the range of 0 -150 mmHg with a sensitivity of 5.9 mG/mmHg (46).
RBF measurement.
After thoracotomy and exposure of the heart, an optical surface suction probe connected to a laser Doppler tissue perfusion monitor (P10d; Moor Instruments) was placed on the surface of the heart at the risk area. RBF was monitored during preischemia, ischemia, and 60 min reperfusion (46) .
Activities of mitochondrial NADH dehydrogenase, succinate cytochrome c reductase (the supercomplex of complex II and III), and cytochrome c oxidase. Heart tissue from the risk area was collected at the end of 60 min reperfusion, followed by homogenizing in ice-cold HEPES buffer (3 mmol/l, pH 7.2) containing sucrose (0.25 mol/l), EGTA (0.5 mmol/l), and protease inhibitor cocktail (1:40; Roche). NADH dehydrogenase (NADH-DH) activity was measured in the presence of Tris · HCl buffer (20 mmol/l, pH 8.0), NADH (150 mol/l; Sigma), and coenzyme Q 1 (100 mol/l; Sigma). Succinate cytochrome c reductase (SCR) activity was measured in the presence of phosphate buffer (50 mmol/l, pH 7.4), EDTA (0.3 mmol/l, pH 7.93), succinate (19.8 mmol/l, pH 8.0; Sigma), and ferricytochrome c (50 mol/l; Sigma). Cytochrome c oxidase (CcO) activity was measured in the presence of phosphate buffer (50 mmol/l, pH 7.4) and reduced cytochrome c (60 mol/l; Sigma). The extinction coefficients, ε 550 nm ϭ 18.5 mmol · l Ϫ1 · cm Ϫ1 for cytochrome c and ε340 nm ϭ 6.22 mmol · l Ϫ1 · cm Ϫ1 for NADH, were used for activity calculation. Protein concentration of tissue homogenate was measured by BCA assay (PIERCE Biotechnology), and the activities were normalized to protein concentrations as nanomoles per milligram protein per minute (44) .
Western blot analysis. Proteins in the homogenate were subjected to electrophoresis on 4 -12% Bis-Tris gradient gels and electrophoretically transferred to nitrocellulose membranes. After being blocked with 5% dry milk in Tween-TBS for 1 h at room temperature, the membranes were incubated with anti-phosphorylated (p)-eNOS (Ser 1177 ) and anti-eNOS antibodies (Cell Signaling). The secondary antibodies were conjugated with horseradish peroxidase, and the protein was detected with enhanced chemiluminescence (Thermo Scientific). The blots were imaged and quantified in a high-performance gel documentation and image analysis system (model 3300; Alpha Innotech, San Leandro, CA).
Infarct size. At the end of 24 h reperfusion, the heart was excised, and the ascending aorta was cannulated for perfusion of 2,3,5-triphenyl tetrazolium chloride (TTC, 3 ml of 1.0%) to stain the infracted tissue. Next, the LAD was reoccluded, and the heart was reperfused with Evans Blue dye (1-2 ml of 2.5%) to demarcate the area at risk (AAR). The heart was then weighed, frozen, and cut into five transverse slices, each with 1 mm thickness. Each slice was photographed from both sides with a high-resolution digital camera on a dissecting microscope. The sections were photographed and contoured with a planimeter (MetaVue Version 6.2r6) to delineate the borders of the entire heart, the nonischemic area, and the infarct area. The sizes of the AAR [total left ventricle (LV) area Ϫ nonischemic area] and the infarct were calculated as percentages of the total LV and AAR multiplied by the weight of that slice and divided by the total heart weight (41, 46) .
Statistical analysis. A two-way ANOVA was used for data analysis of PO 2, RBF, AAR, and infarct size. A one-way ANOVA was used for enzyme activities and protein expression; these were followed by Student-Newman-Keuls multiple-comparison test among the groups. Generally, the number of animals was five per group, and all data were analyzed in a blinded fashion. The final data were represented as means Ϯ SE. A value of P Ͻ 0.05 was considered significant. end of 60 min reperfusion. There were no significant differences between the two groups and between the pre-and postischemic states in each group. The transient peak of PO 2 at ϳ15 min reperfusion in the I/R group probably reflected a reactive hyperemia phenomenon that disappeared with the increase of ischemia time. As shown in Fig. 1B on the 30-min I/R and I/R ϩ IPOC groups, baseline values of tissue PO 2 in the preischemic states were 12.4 Ϯ 0.6 and 11.5 Ϯ 0.3 mmHg, respectively. In both groups, PO 2 values first dropped rapidly following the onset of LAD occlusion and then decreased gradually to values of 0.5 Ϯ 0.1 and 1.2 Ϯ 0.5 mmHg in the I/R and I/R ϩ IPOC groups. After reperfusion, tissue PO 2 increased gradually and overshot the preischemic levels, with 18.9 Ϯ 0.6 (P Ͻ 0.001) and 16.6 Ϯ 2.0 mmHg (P ϭ 0.004) observed at the end of 60 min reperfusion in the I/R and I/R ϩ IPOC groups. As shown in Fig. 1C , when the ischemic duration was extended to 45 min, the PO 2 value in the I/R group overshot the preischemic level (18.2 Ϯ 0.9 vs. 11.5 Ϯ 0.3 mmHg, P Ͻ 0.001) at 60 min reperfusion. However, the PO 2 level in the I/R ϩ IPOC mice increased only to a value of 14.1 Ϯ 0.6 mmHg at 60 min reperfusion with no overshoot over the preischemic value of 12.1 Ϯ 0.4 mmHg. As shown in Fig. 1D , when the ischemic time was extended to 60 min, there was no overshoot of tissue PO 2 after reperfusion in the I/R mice (12.0 Ϯ 1.1 vs. 12.5 Ϯ 0.3 mmHg in the preischemic state). However, tissue PO 2 overshot the basal level in the I/R ϩ IPOC mice (16.3 Ϯ 0.8 vs. 12.7 Ϯ 0.3 mmHg, P Ͻ 0.001) at the end of 60 min reperfusion. These results demonstrated that postischemic myocardial tissue hyperoxygenation only appeared within an ischemic time window between 30 and 45 min, and IPOC affected postischemic tissue oxygenation differently with different ischemic time.
RBF measurement. Because tissue PO 2 is a balance between oxygen supply and consumption, to understand how I/R and IPOC affect postischemic myocardial tissue oxygen supply, RBF in the AAR was measured. Because 15 min ischemia would not change all major parameters measured in this study (such as postischemic myocardial oxygenation and myocardial infarction), the 15 min ischemic time duration is omitted for the following measurements. As shown in Fig. 2A (30 min ischemic time), there were no differences before and during ischemia between the two groups. However, after 60 min reperfusion, the RBF value reached a level of 7.2 Ϯ 0.2 arbitrary units (AU) in the I/R ϩ IPOC group, which was significantly higher than that of the basal value (6.2 Ϯ 0.4 AU, P ϭ 0.007) and that in the I/R mice (5.3 Ϯ 0.4 AU, P ϭ 0.002). When the ischemic time was extended to 45 min (as shown in Fig. 2B ), the value of RBF reached a level of 5.3 Ϯ 0.2 AU in the I/R ϩ IPOC group, which is lower than that of the preischemic value of 6.2 Ϯ 0.2 AU (P ϭ 0.008) but still higher than that in the I/R group (4.3 Ϯ 0.1 AU, P ϭ 0.004). When the ischemic time was extended to 60 min as shown in Fig. 2C , the values of RBF after reperfusion decreased markedly compared with the baseline values in both the I/R and I/R ϩ IPOC groups (3.9 Ϯ 0.2 vs. 6.2 Ϯ 0.4 AU, P ϭ 0.001; and 4.2 Ϯ 0.4 vs. 6.2 Ϯ 0.4 AU, P ϭ 0.016), and there was no significant difference between the two groups. These results illustrated that, while I/R decreased postischemic RBF to different levels with different ischemic time, IPOC improved RBF only within the 30-to 45-min ischemic time window.
Mitochondrial NADH-DH, SCR, and CcO activities. To determine how I/R and IPOC affect myocardial oxygen consumption with different ischemic time window, mitochondrial enzyme NADH-DH, SCR, and CcO activities were measured. As shown in Fig. 3A , P ϭ NS). These results indicated that, while I/R generally decreased mitochondrial enzyme activities (with an exception of CcO in the 30-min I/R group), IPOC improved the activities of these enzymes only within an ischemic time window from 30 to 45 min.
eNOS activity in the postischemic heart with different ischemic time durations. It is well established that eNOS-derived NO is a potent vasodilator. To understand how RBF was regulated during I/R and IPOC, eNOS activity, represented as the ratio of p-eNOS (Ser 1177 ) over total eNOS, was measured (26) . Figure 4A shows a representative Western blot of p-eNOS and total eNOS protein expression. As shown in Fig. 4B , the Fig. 2 . Regional blood flow (RBF) measurements in the area at risk. RBF was measured before ischemia, during 30 (A), 45 (B), and 60 (C) min ischemia, and 60 min reperfusion in the I/R and I/R ϩ IPOC groups (n ϭ 5/group). I/R decreased the postischemic RBF with the extension of ischemic time. IPOC improved RBF in the 30-and 45-min groups (*P ϭ 0.007 vs. preischemic level; **P ϭ 0.002 vs. 30-min I/R group; ϩP ϭ 0.008 vs. preischemic level; ϩϩP ϭ 0.004 vs. 45-min I/R group). However, IPOC had no effect on RBF in the 60-min I/R group (#P ϭ 0.001 and ##P ϭ 0.016 vs. preischemic state with no difference between the two). Infarct size. To characterize the end-point I/R injury and IPOC protection, the ratio of AAR over the area of LV and the infarct size over the AAR was measured in all groups. Figure 5A shows the representative heart slices from the I/R (top) and the I/R ϩ IPOC (bottom) groups with a different ischemic time window. As shown in Fig. 5B , there were no significant differences in the ratio of AAR over LV among all eight groups. Figure 5C shows the infarct size as 32.2 Ϯ 0.7, 37.9 Ϯ 0.7, and 45.6 Ϯ 3.8% of AAR with 30, 45, and 60 min of LAD occlusion followed by 24 h of reperfusion. Compared with the respective I/R groups, IPOC significantly reduced the infarct size to 12.4 Ϯ 2.2 and 21.0 Ϯ 1.3% (P Ͻ 0.001) in the 30-and 45-min I/R ϩ IPOC groups. However, IPOC had no cardioprotection when the ischemic duration was extended to 60 min (46.4 Ϯ 2.9 vs. 45.6 Ϯ 3.8% in the I/R group). There was no observable infarction in the 15-min I/R and I/R ϩ IPOC groups in our model.
The effect of L-NAME treatment on myocardial tissue oxygenation, RBF, mitochondrial enzyme activities, and myocardial infarction.
To further determine whether or not NOS is responsible for the protection of IPOC on RBF, mitochondrial function, and myocardial infarction, and since IPOC only induced an overshoot of tissue oxygenation in the 30-min ischemic group, L-NAME was given 3 days before ischemia in the 30-min I/R ϩ IPOC mice.
As shown in Fig. 6A , EPR oximetry measurements were stable in the experimental time period, and L-NAME treatment completely attenuated the overshoot of tissue PO 2 in the I/R ϩ IPOC mice (as shown in Fig. 1B) to the level comparable to that in the preischemic state (11.6 Ϯ 0.8 mmHg at 60 min reperfusion vs. 12.5 Ϯ 0.4 mmHg at the beginning of ischemia). Figure 6B shows that L-NAME blunted the increase of RBF in the I/R ϩ IPOC mice to the level comparable to that in the I/R mice as shown in Fig. 2A (5.4 Ϯ 0. 1 vs. 5.4 Ϯ 0.4 AU at 60 min reperfusion). Because L-NAME had no effect on RBF in the I/R mouse heart (44) , these data demonstrated that the IPOC-induced higher RBF in the I/R ϩ IPOC mice was due to NOS-derived NO, and NOS was also responsible for the overshoot of tissue PO 2 in the I/R ϩ IPOC mice.
As shown in Fig. 7 , L-NAME treatment did not significantly alter the activities of NADH-DH, SCR, and CcO in the L-NAME ϩ I/R ϩ IPOC mice (105. Fig. 3 ). These results indicated no additive effect of L-NAME to IPOC on mitochondrial enzyme activities and further demonstrated that the overshoot of tissue PO 2 in the I/R ϩ IPOC mice was due to the upregulation of NOS activity and preserved mitochondrial function.
Finally, myocardial infarction was measured in the L-NAME ϩ I/R ϩ IPOC mouse heart. As shown in Fig. 8 , L-NAME treatment did not significantly alter the AAR/LV and infarct size/AAR compared with that in the I/R ϩ IPOC mice (69.7 Ϯ 2.0 and 15.9 Ϯ 1.1% vs. 64.1 Ϯ 1.1 and 12.4 Ϯ 2.2%, as shown in Fig. 5 ). These results paralleled the effect of L-NAME on the mitochondrial enzyme activities.
DISCUSSION
Postconditioning is cardioprotective and improves long-term functional recovery after myocardial infarction (28, 37) . A number of clinical studies have also demonstrated its potential cardioprotection in ischemic heart disease (35) . The underlying mechanisms for IPOC involve triggers, mediators, and endeffectors: contribution of each individual signal may vary depending on the model (cell type, in vitro or in vivo) and the stimulus algorithm used. Most likely, these pathways are redundant to guarantee a robust protection by IPOC.
A prior excellent study has demonstrated in a rat heart model that cardioprotection of IPOC depends on the duration of index ischemia (25) . There, the phosphatidylinositol 3-kinase (PI 3-kinase)-protein kinase B (Akt)-eNOS pathway and superoxide formation were investigated, and the involvement of mitochondrial permeability transition pore was speculated for the protection of IPOC (11, 23) . However, the exact mechanisms responsible for the existence of a salvageable ischemic time window are still elusive. Previously, we have demonstrated that myocardial tissue oxygenation is a sensitive indicator of the balance between oxygen supply and consumption with postischemic hyperoxygenation, indicating impaired mitochondrial oxygen metabolism due to I/R-induced ROS/RNS formation, given the fact that oxygen supply through RBF is generally reduced due to I/R-induced vascular damage (44) . In addition, we have also demonstrated that ischemic preconditioning attenuates postischemic myocardial tissue hyperoxygenation and protects the heart from I/R injury (46) . To understand the underlying mechanisms for cardioprotection of IPOC, the current study focused on its relationship with myocardial oxygen supply (vascular activity) and metabolism (mitochondrial function) to determine how a salvageable ischemic time window was defined.
As observed, with 30 min ischemia, the postischemic myocardial tissue PO 2 overshot the baseline values in both the I/R and I/R ϩ IPOC groups with no significant difference between the two. However, the mechanisms responsible for the overshoots in the two groups were different. In the 30-min I/R mouse heart, because the RBF was decreased compared with the preischemic state, the overshoot of tissue PO 2 suggested that mitochondrial oxygen consumption may be impaired, which was confirmed by the mitochondrial enzyme activity measurements (Fig. 3 , except that of the CcO) and consistent with our previous studies (41, 44, 46) . However, in the 30-min I/R ϩ IPOC mouse heart, IPOC increased the RBF compared with the basal value and restored the mitochondrial enzyme activities. Therefore, the overshoot of PO 2 in this group is due to the improvement of RBF rather than the impairment of mitochondrial oxygen consumption. With L-NAME treatment, it was further determined that NOS activity was responsible for the improvement of RBF in the I/R ϩ IPOC mice. With ischemic time extended to 45 min, the postischemic tissue PO 2 Tissue oxygenation and RBF were measured before, during, and after 30 min ischemia in the L-NAME ϩ I/R ϩ IPOC mice. A: tissue PO2 in the sham control (OE) and L-NAME ϩ I/R ϩ IPOC () mice. L-NAME treatment completely attenuated the overshoot of tissue PO2 in the I/R ϩ IPOC mice as shown in Fig. 1B . B: L-NAME blunted the increase of RBF in the I/R ϩ IPOC mice as shown in Fig. 2A (n ϭ 5/group). overshot the baseline in the I/R but not IPOC group. This is due to the integrated effect of I/R and IPOC on RBF and mitochondrial enzyme activities (Figs. 2 and 3 ). With 60 min ischemia, due to severely suppressed RBF and mitochondrial enzyme activities, there was no overshoot of tissue PO 2 in the I/R group. The overshoot of tissue PO 2 in the IPOC group may reflect additional damage from the IPOC stimuli. Interestingly, the appearance of the postischemic hyperoxygenation in the 30-and 45-min I/R groups mirrored the existence of a salvageable ischemic time window shown in Fig. 5C .
To further study how RBF was regulated by I/R and IPOC, we measured the activity of eNOS (phosphorylation at Ser 1177 ) in all groups, since endothelium-derived NO regulates vascular and cardiac function. The improvement of RBF by IPOC could be due to increased NO production and vasodilation by eNOS phosphorylation. We have observed that the level of eNOS phosphorylation was decreased gradually in the I/R groups with the extension of ischemic time, which is consistent with previous studies (8) . IPOC restored the phosphorylation of eNOS with 30 and 45 but not 60 min ischemia. The fact that the p-eNOS/eNOS level was even higher than that in the preischemic state in the 30-min I/R ϩ IPOC group may explain why the RBF was higher than that in the preischemic state and why there was an overshoot of tissue PO 2 in the 30-min I/R ϩ IPOC group. These data suggest that IPOC protects the mouse heart against I/R injury via eNOS-regulated RBF within a limited ischemic time window. Failure to restore the reperfusion RBF with 60 min ischemia may underlie the protective role of RBF responsible for the loss of cardioprotection afforded by IPOC, which is consistent with previous findings (10) . However, our study does not exclude other previously reported prosurvival signaling cascades such as PI 3-kinaseAkt and p70s6K (38) .
Because tissue oxygenation is also determined by oxygen consumption, we assessed postischemic mitochondrial function by measuring mitochondrial enzyme activities. Generally, I/R suppressed mitochondrial enzyme activities with more severe suppression at longer ischemic time. IPOC protected the activities of these enzymes at 30 and 45 but no 60 min ischemia. L-NAME treatment did not add additional protection of IPOC to the mitochondrial function.
Last, with Evans blue and TTC staining of the AAR and infarct size, we illustrated that IPOC induced cardioprotection with 30 and 45 min ischemia, which is consistent with previous reports (7, 19, 42) . Again, L-NAME treatment did not add additional protection of IPOC. When the ischemic duration was Ͻ30 or Ͼ45 min, the protection was lost. This may be due to the loss of improvement on both RBF and mitochondrial function at the high end and no protectable I/R injury at the low end of the ischemic time window.
Admittedly, although our study demonstrated that there was no protection of IPOC after an index ischemia of 60 min, which is consistent with several reports that have similarly failed to observe a cardioprotective effect at 60 min ischemia, (22, 32, 39) other studies, including in humans (24, 35) , have also shown that IPOC was cardioprotective even with 60 min ischemia (1, 7, 18, 38) . We believe that these discrepancies could be explained by species differences. Another limitation of this study is that we didn't fully explore all postconditioning stimuli algorithms and their relationships with the salvageable ischemic time window, since different numbers and durations of postconditioning cycles are needed in different species such as rats, pigs, and rabbits to establish IPOC protection (5, 15, 25) . Our stimuli algorithm of three cycles of 10 s/10 s I/R clearly offered protection within 30 and 45 min ischemia. Further studies are warranted in this regard to define an algorithm to prolongate the salvageable ischemic time window in addition to the maximization of IPOC protection.
In conclusion, our data demonstrated that a salvageable ischemic time window of IPOC protection was determined by eNOS-regulated RBF and mitochondrial metabolismregulated myocardial oxygen consumption. Interestingly, Fig. 7 . The effect of L-NAME and IPOC on mitochondrial enzyme activities. The activities of NADH-DH, SCR, and CcO were measured in the L-NAME ϩ I/R ϩ IPOC mice. As shown, L-NAME treatment did not significantly alter the activities of these enzymes in the I/R ϩ IPOC mice (105.70 Ϯ 3.58, 25.67 Ϯ this ischemic time window was mirrored by the appearance of postischemic myocardial tissue hyperoxygenation. It is tempting to speculate that this tissue hyperoxygenation may be an indicator for tissue salvageability by IPOC. Understanding these mechanisms is critical to gain further insights in the protection of IPOC.
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